Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 46.37%248.57M | 58.38%98.5M | -31.16%29.55M | 27.56%57.21M | 218.90%63.31M | -15.45%169.82M | 62.19M | 123.38%42.93M | 44.85M | -53.66%19.85M |
| Cost of revenue | 63.31%189.1M | 28.96%53.29M | 20.50%48.51M | 42.72%43.24M | 1,024.42%44.07M | -35.17%115.79M | 41.32M | 51.32%40.26M | 30.3M | -88.95%3.92M |
| Gross profit | 10.07%59.47M | 116.66%45.21M | -809.77%-18.96M | -4.02%13.97M | 20.78%19.25M | 142.69%54.03M | 20.87M | 136.16%2.67M | 14.56M | 115.97%15.93M |
| Operating expense | 18.87%10.85M | -3.35%3.52M | -96.57%55K | -268.07%-2.8M | 171.75%2.41M | -51.35%9.13M | 3.65M | 116.17%1.6M | 1.67M | -59.20%885K |
| Selling and administrative expenses | 48.82%8.31M | 43.58%2.89M | 6.48%1.3M | 17.13%1.72M | 171.75%2.41M | -62.67%5.59M | --2.01M | --1.22M | --1.47M | -64.63%885K |
| -General and administrative expense | 48.82%8.31M | 43.58%2.89M | 6.48%1.3M | 17.13%1.72M | 171.75%2.41M | -62.67%5.59M | --2.01M | --1.22M | --1.47M | -64.63%885K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -33.33%2.53M | ---- | ---- | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Amortization | ---- | ---- | ---- | ---- | ---- | -33.33%2.53M | ---- | ---- | ---- | ---- |
| Other operating expenses | -28.40%2.53M | -61.04%637K | 100.16%1.27M | ---- | ---- | --3.54M | --1.64M | 0.00%632K | --638K | ---- |
| Total other operating income | ---- | ---- | 911.69%2.51M | 920.99%4.52M | ---- | ---- | --1.9M | -97.65%248K | --443K | ---- |
| Operating profit | 8.28%48.62M | 142.06%41.69M | -1,881.91%-19.01M | 30.11%16.77M | 11.90%16.84M | 1,180.89%44.9M | 17.22M | -57.93%1.07M | 12.89M | 188.90%15.05M |
| Net non-operating interest income (expenses) | 41.74%-589K | 38.16%-128K | 43.78%-131K | 43.70%-152K | 40.86%-178K | 43.83%-1.01M | -207K | 39.16%-233K | -270K | 2.59%-301K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | 516.18%1.51M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -41.74%589K | -38.16%128K | -43.78%131K | -43.70%152K | -40.86%178K | -50.58%1.01M | --207K | -39.16%233K | --270K | -2.59%301K |
| Net investment income | -67.03%578K | -78.50%106K | 645.12%1.75M | 493K | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 72.05%-485K | 72.05%-485K | 0 | 0 | -191.83%-1.74M | -1.74M | ||||
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | 681.31%7.74K | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | 6.99%-892.02K | ---- | ---- | ---- | ---- |
| Less:Write off | -72.05%485K | -72.05%485K | ---- | --0 | --0 | 286.28%1.74M | --1.74M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 461.15%8.71M | 8.42%1.52M | -103.53%-3K | 26.84%1.55M | 1.4M | 113.45%85K | ||||
| Income before tax | 25.02%56.83M | 148.62%42.7M | -2,395.44%-19.14M | 31.69%16.62M | 12.31%16.66M | 910.92%45.46M | 17.18M | -61.26%834K | 12.62M | 247.62%14.83M |
| Income tax | 78.22%23.07M | 186.03%17.3M | 770K | -9.27%2.86M | -42.83%2.14M | 271.27%12.94M | 6.05M | 0 | 3.15M | 198.64%3.75M |
| Net income | 3.84%33.77M | 128.30%25.41M | -2,487.77%-19.91M | 45.32%13.76M | 30.93%14.52M | 3,116.17%32.52M | 11.13M | -61.26%834K | 9.47M | 268.01%11.09M |
| Net income continuous operations | 3.84%33.77M | 128.30%25.41M | -2,487.77%-19.91M | 45.32%13.76M | 30.93%14.52M | 3,116.17%32.52M | --11.13M | -61.26%834K | --9.47M | 268.01%11.09M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3.84%33.77M | 128.30%25.41M | -2,487.77%-19.91M | 45.32%13.76M | 30.93%14.52M | 3,116.17%32.52M | 11.13M | -61.26%834K | 9.47M | 268.01%11.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3.84%33.77M | 128.30%25.41M | -2,487.77%-19.91M | 45.32%13.76M | 30.93%14.52M | 3,116.17%32.52M | 11.13M | -61.26%834K | 9.47M | 268.01%11.09M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.70%0.0185 | 87.84%0.0139 | -1,657.14%-0.0109 | 0.00%0.0076 | -10.11%0.008 | 3,012.50%0.0249 | 0.0074 | -58.82%0.0007 | 0.0076 | 270.83%0.0089 |
| Diluted earnings per share | -24.49%0.0185 | 90.41%0.0139 | -2,280.00%-0.0109 | 0.00%0.0076 | -10.11%0.008 | 2,962.50%0.0245 | 0.0073 | -70.59%0.0005 | 0.0076 | 456.25%0.0089 |
| Dividend per share | 0.025 | 0 | 0.01 | 0 | 0.015 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.